Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016

Date: December 1, 2016
Pages: 70
Price:
US$ 2,650.00 US$ 2,200.00 (This month only)
License [?]:
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: GED8D21A893EN
Leaflet:

Download PDF Leaflet

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016 aims at providing comprehensive data on gemtuzumab ozogamicin market globally and regionally (Europe, Asia, North America, Latin America etc.)

The report includes gemtuzumab ozogamicin description, covers its application areas, manufacturing methods, patents. It captures gemtuzumab ozogamicin market trends, pays close attention to gemtuzumab ozogamicin manufacturers and names suppliers.

Besides, the report provides gemtuzumab ozogamicin prices in regional markets.

In addition to the above the report determines gemtuzumab ozogamicin consumers.

Our research team can supply with valuable information on the following positions for each chemical product in any country or region:

  • present market conditions
  • plants’ capacity and production
  • amount and structure of demand
  • export and import
  • prices in the market
  • existing technologies an patents
  • feedstock analysis
  • future market development
  • etc.
Thus, Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016 can provide:
  • gemtuzumab ozogamicin ranges, trademarks, analogous products, application areas, manufacturing methods
  • present gemtuzumab ozogamicin market conditions, prices
  • gemtuzumab ozogamicin market forecast, estimations
  • gemtuzumab ozogamicin manufacturers, consumers and traders (including contact details)

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016 contents were prepared and placed on the website in December, 2016. As a special offer the report price was cut and now is as low as US$ 2,200.00. Do not lose the chance to order this Market Report for almost half-price.

1. GEMTUZUMAB OZOGAMICIN (CAS 16320-04-0)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. GEMTUZUMAB OZOGAMICIN APPLICATIONS

2.1. Gemtuzumab ozogamicin application spheres, downstream products

3. GEMTUZUMAB OZOGAMICIN MANUFACTURING METHODS

4. GEMTUZUMAB OZOGAMICIN PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. GEMTUZUMAB OZOGAMICIN MARKET WORLDWIDE

5.1. General gemtuzumab ozogamicin market situation, trends
5.2. Manufacturers of gemtuzumab ozogamicin
  - Europe
  - Asia
  - North America
  - Other regions
5.3. Gemtuzumab ozogamicin suppliers (importers, local distributors)
  - Europe
  - Asia
  - North America
  - Other regions
5.4. Gemtuzumab ozogamicin market forecast

6. GEMTUZUMAB OZOGAMICIN MARKET PRICES

6.1. Gemtuzumab ozogamicin prices in Europe
6.2. Gemtuzumab ozogamicin prices in Asia
6.3. Gemtuzumab ozogamicin prices in North America
6.4. Gemtuzumab ozogamicin prices in other regions

7. GEMTUZUMAB OZOGAMICIN END-USE SECTOR

7.1. Gemtuzumab ozogamicin market by application sphere
7.2. Gemtuzumab ozogamicin downstream markets trends and prospects
7.3. Gemtuzumab ozogamicin consumers globally
  - Europe
  - Asia
  - North America
  - Other regions

*Please note that Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.
Product Name:Gemtuzumab Ozogamicin
Synonyms:
  • (8S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
  • 13-beta-Ethyl-17-alpha-ethinyl-17-hydroxy-gona-4,9,11-triene-3-one
  • 13-Ethyl-17-alpha-ethynyl-17-hydroxygon-4,9,11-trien-3-one
  • 13-Ethyl-17-hydroxy-18,19-dinor-17-alpha-pregna-4,9,11-trien-20-yn-3-one
  • Ethylnorgestrienone
CAS#:16320-04-0
Formula:C21H24O2
Molecular Weight:308.41
Structure: (CAS 16320-04-0)

Skip to top


Ask Your Question

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: